Cogrinding as an approach to enhance dissolution rate of a poorly water-soluble drug (gliclazide)

Powder Technology

Volumn 197, Issue 3, 2010, Pages 150-158

  Barzegar Jalali, Mohammad ^a,b   Valizadeh, Hadi ^a,c   Shadbad, Mohammad Reza Siahi ^a   Adibkia, Khosro ^a   Mohammadi, Ghobad ^a,d   Farahani, Amin ^a,b   Arash, Zeynab ^a,b   Nokhodchi, Ali ^e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Carrier; Cogrinding; Dissolution enhancement; DSC; Gliclazide; Solid dispersion; X ray diffraction

Indexed keywords

CARRIER; CO-GRINDING; CONCENTRATION OF; CROSPOVIDONE; CRYSTALLINITIES; DEAGGREGATION; DISSOLUTION RATES; DRUG DISSOLUTION; FTIR SPECTROSCOPY; GLICLAZIDE; INSOLUBLE DRUG; INTESTINAL FLUID; MICROCRYSTALLINE CELLULOSE; PHYSICAL MIXTURES; PHYSIOLOGICAL PH; POORLY WATER-SOLUBLE DRUGS; SOLID DISPERSION; UV SPECTROSCOPY;

DIFFRACTION; DIFFUSERS (OPTICAL); DISPERSIONS; DRUG DOSAGE; DRUG INTERACTIONS; HYDROPHILICITY; MICROCRYSTALS; OPTICAL GLASS; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; PH EFFECTS; SCANNING ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION; X RAY DIFFRACTION ANALYSIS;

DISSOLUTION;

CROSPOVIDONE; DRUG CARRIER; GLICLAZIDE; MICROCRYSTALLINE CELLULOSE; POVIDONE; WATER;

ARTICLE; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRYSTALLIZATION; CULTURE MEDIUM; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG CAPSULE; DRUG FORMULATION; DRUG SOLUBILITY; HYDROPHILICITY; INFRARED SPECTROSCOPY; INTESTINE FLUID; PARTICLE SIZE; PH; POWDER; SCANNING ELECTRON MICROSCOPY; STOMACH JUICE; TABLET FORMULATION; TABLET MANUFACTURE; ULTRAVIOLET SPECTROSCOPY; WETTABILITY; X RAY DIFFRACTION;

EID: 70449658823     PISSN: 00325910     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.powtec.2009.09.008     Document Type: Article

References (48)

1. Kubo H., Osawa T., Takashima K., and Mizobe M. Enhancement of oral bioavailability and pharmacological effect of 1-(3, 4-dimethoxyphenyl)-2, 3-bis(methoxycarbonyl)-4-hydroxy-6, 7, 8-trimethoxynapthalene (TA-7552), a new hypocholesterolemic agent by micronization in coground mixture with d-mannitol. Biol. Pharm. Bull. 19 (1996) 741-747
2. Martis L., Hall N.A., and Thakkar A.L. Micelle formation and testerone solubilization by sodium glycocholate. J. Pharm. Sci. 61 (1972) 1757-1761
3. Rees J.A., and Collett J.H. The dissolution of salicylic acid in micellar solutions of polysorbate-20. J. Pharm. Pharmacol. 26 (1974) 956-960
4. Casella R., Williams D.A., and Jambhekar S.S. Solid state cyclodextrin complexes containing indomethacin, ammonia and water. II. Solubility studies. Int. J. Pharm. 165 (1998) 1-14
5. Trapani G., Latrofa A., Franco M., Lopedota A., Maciocco E., and Liso G. Water-soluble salts of aminoacid esters of the anaesthetic agent propofol. Int. J. Pharm. 17 (1998) 195-204
6. Spireas S., and Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int. J. Pharm. 166 (1998) 177-188
7. Spireas S., Wang T., and Grover R. Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts. Drug Dev. Ind. Pharm. 25 (1999) 163-168
8. Javadzadeh Y., Siahi M.R., Barzegar Jalali M., and Nokhodchi A. Enhancement of dissolution rate of piroxicam using liquisolid compacts. IL Farmaco 60 (2005) 361-365
9. Javadzadeh Y., Siahi M.R., Asnaashari S., and Nokhodchi A. An investigation on physicochemical properties of piroxicam liquisolid compacts. Drug Dev. Technol. 12 (2007) 337-343
10. Nokhodchi A., Javadzadeh Y., Siahi M.R., and Barzegar-Jalali M. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J. Pharm. Pharmaceut. Sci. 8 (2005) 18-25
11. Kapsi S.G., and Ayres J.W. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int. J. Pharm. 229 (2001) 193-203
12. Barzegar-Jalali M., and Dastmalchi S. Kinetic analysis of chlorpropamide dissolution from solid dispersions. Drug Dev. Ind. Pharm. 33 (2007) 63-70
13. Barzegar-Jalali M., Valizadeh H., Dastmalchi S., Siahi-Shadbad M.R., Barzegar-Jalali A., Adibkia K., and Mohammadi G. Enhancing dissolution rate of carbamazepine via cogrinding with crospovidone and hydroxypropyl methylcellulose. Iran. J. Pharm. Res. 6 (2007) 159-165
14. Nokhodchi A., Talari R., Valizadeh H., and Barzegar-Jalali M. An investigation on the solid dispersions of chordazepoxide. Int. J. Biomed. Sci. 3 (2007) 211-217
15. Valizadeh H., Nokhodchi A., Qarakhani N., Zakeri-Milani P., Azarmi S., Hassan-zadeh D., and Lobenberg R. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrij 52, Lactose, Sorbitol, dextrin, and Eudragit E100. Drug Dev. Ind. Pharm. 30 (2004) 303-317
16. Valizadeh H., Zakeri-Milani P., Barzegar-Jalali M., Mohammadi G., Danesh-Bahreini M.A., Adibkia K., and Nokhodchi A. Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev. Ind. Pharm. 33 (2007) 45-56
17. Aguiar A.J., Zelmer A.J., and Kinkel A.W. Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt. J. Pharm. Sci. 56 (1979) 1243-1252
18. Finholt P., and Solvang S. Dissolution kinetics of drugs in human gastric juice the role of surface tension. J. Pharm. Sci. 57 (1968) 1322-1326
19. Lin S.L., Menig J., and Lachman L. Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs. J. Pharm. Sci. 57 (1968) 2143-2146
20. Chiou W.L., and Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60 (1971) 1281-1302
21. Ford J.L. The current status of solid dispersions. Pharm. Acta Helv. 61 (1986) 69-88
22. Barzegar-Jalali M., Nayebi A.M., Valizadeh H., Hanaee J., Barzegar-Jalali A., Adibkia K., Anoush M., and Sistanizad M. Evaluation of in vitro-in vivo correlation and anticonvulsive effect of carbamazepine after cogrinding with microcrystalline cellulose. J. Pharm. Pharmaceut. Sci. 9 (2006) 307-316
23. Barzegar-Jalali M., Maleki N., Garjani A., Khandar A.A., Haji-Hosseinloo M., Jabbari R., and Dastmalchi S. Enhancement of dissolution rate and anti-inflammatory effects of piroxicam using solvent deposition technique. Drug Dev. Ind. Pharm. 28 (2002) 681-686
24. Dastmalchi S., Garjani A., Maleki N., Sheikhee G., Baghchevan V., Jafari-Azad P., Valizadeh H., and Barzegar-Jalali M. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. J. Pharm. Pharmaceut. Sci. 8 (2005) 175-181
25. Verheyen S., Blaton N., Kingrt R., and Van den mooter G. Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions. Int. J. Pharm. 249 (2002) 45-58
26. Ruan L.P., Yu B.Y., Fu G.M., and Zhu D.N. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal. 38 (2005) 457-464
27. Sethia S., and Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int. J. Pharm. 272 (2004) 1-10
28. Ohara T., Kitamura S., Kitagawa T., and Terada K. Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose. Int. J. Pharm. 302 (2005) 95-102
29. Saito M., Ugajin T., Nozawa Y., Sadzuka Y., Miyagishima A., and Sonobe T. Preparation and dissolution characteristics of griseofulvin solid dispersions with saccharides. Int. J. Pharm. 249 (2002) 71-79
30. Cui F., Yang M., Jiang Y., Cun D., Lin W., Fan Y., and Kawashima Y. Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. J. Contemp. Relig. 91 (2003) 375-384
31. Craig D.Q.M. Polyethylene glycols and drug release. Drug Dev. Ind. Pharm. 16 (1990) 2501-2526
32. Craig D.Q.M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 23 (2002) 131-144
33. Corrigan O.I. Mechanisms of dissolution of fast release solid dispersions. Drug Dev. Ind. Pharm. 11 (1985) 697-724
34. Yuksel N., Karatas A., Ozkanb Y., Savaser A., Ozkan S.A., and Baykara T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 56 (2003) 453-459
35. Asada M., Takahashi H., Okamoto H., Tanino H., and Danjo K. Theophylline particle design using chitosan by the spray drying. Int. J. Pharm. 270 (2004) 167-174
36. Rodier E., Lochard H., Sauceau M., Letourneau J.J., Freiss B., and Fages J. A three step supercritical process to improve the dissolution rate of Eflucimibe. Eur. J. Pharm. Sci. 26 (2005) 184-193
37. Higuchi T., and Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Instr. 4 (1965) 117-212
38. Betageri G.V., and Makarla K.R. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques. Int. J. Pharm. 126 (1995) 155-160
39. Trapani G., Franco M., Latrofa A., Pantaleo M.R., Sanna E., Maciocco E., and Liso G. Physicochemical characterization and in vivo properties of Zolpidem in solid dispersions with polyethylene glycol 4000 and 6000. Int. J. Pharm. 184 (1999) 121-130
40. Guyot M., Fawaz F., Bildet J., Bonini F., and Legueny A.M. Physicochemical characterization and dissolution of norfloxacin/cyclodextrin inclusion compounds and solid dispersions. Int. J. Pharm. 123 (1995) 53-63
41. Shokri J., Hanaee J., Barzegar-Jalali M., Changizi R., Rahbar M., and Nokhodchi A. Improvement of the dissolution rate of indomethacin by a cogrinding technique using polyethylene glycols of various molecular weights. Drug Del. Sci. Tech. 16 (2006) 203-209
42. Arias M.J., Gines J.M., Moyano J.R., and Rabasco A.M. Dissolution properties and in vivo behavior of triamterene in solid dispersions with polyethylene glycols. Pharm. Acta Helv. 71 (1996) 229-235
43. Ozkan Y., Atay T., Dikmen N., Isimer A., and Aboul-Enein H.Y. Improvement of water solubility and in vitro dissolution rate of gliclazide by complexation with betacyclodextrin. Pharm. Acta Helv. 74 (2000) 365-370
44. Sekikawa H., Naanuma T., Fujiwara J., Nakano M., and Arita T. Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-PVP coprecipitate. Chem. Pharm. Bull. 27 (1970) 1223-1230
45. Karavas E., Ktistis G., Xenakis A., and Georgarakis E. Effect of hydrogen bonding interactions on the release mechanism of felodipine from nanodispersions with polyvinylpyrrolidone. Eur. J. Pharm. Biopharm. 63 (2006) 103-114
46. Doherty C., and York P. Mechanisms of dissolution of frusemide/PVP solid dispersion. Int. J. Pharm. 34 (1987) 197-205
47. Özkan Y., Doganay N., Dikmen N., and Isimer A. Enhanced release of solid dispersions of etodolac in polyethylene glycol. IL Farmaco 55 (2000) 433-438
48. Gibson M. Pharmaceutical Preformulation and Formulation-a Practical Guide from Candidate Drug Selection to Commercial Dosage Form. HIS Health Group, Englewood (2001)